Gut compound identified as next target for reducing Alzheimer's risk
September 02, 2026
September 02, 2026
MADISON, Wisconsin, Sept. 2 -- The University of Wisconsin School of Medicine and Public Health posted the following news:
* * *
Gut compound identified as next target for reducing Alzheimer's risk
*
Higher levels of imidazole propionate (ImP), a compound produced by some bacteria in the gut, contribute to dementia-related changes in the brain, according to a new study led by Barbara Bendlin, PhD, a professor of medicine and Federico Rey, . . .
* * *
Gut compound identified as next target for reducing Alzheimer's risk
*
Higher levels of imidazole propionate (ImP), a compound produced by some bacteria in the gut, contribute to dementia-related changes in the brain, according to a new study led by Barbara Bendlin, PhD, a professor of medicine and Federico Rey, . . .